Virginiamycin Market, Global Outlook and Forecast 2022-2028
Virginiamycin is a streptogramin antibiotic produced by Streptomyces virginiae as a mixture of two macrocyclic lactone peptolides, Virginiamycin is used in the fuel ethanol industry to prevent microbial contamination.
This report contains market size and forecasts of Virginiamycin in global, including the following market information:
Global Virginiamycin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Virginiamycin Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Virginiamycin companies in 2021 (%)
The global Virginiamycin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Poultry Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Virginiamycin include Phibro Animal Health Corporation, Zoetis, Elanco, Merck Animal Health, Merial, Bayer Animal Health, Virbac, Ceva and Boehringer Ingelheim and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Virginiamycin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Virginiamycin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Virginiamycin Market Segment Percentages, by Type, 2021 (%)
Global Virginiamycin Market Segment Percentages, by Application, 2021 (%)
Global Virginiamycin Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Virginiamycin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Virginiamycin revenues share in global market, 2021 (%)
Key companies Virginiamycin sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Virginiamycin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Virginiamycin in global, including the following market information:
Global Virginiamycin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Virginiamycin Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Virginiamycin companies in 2021 (%)
The global Virginiamycin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Poultry Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Virginiamycin include Phibro Animal Health Corporation, Zoetis, Elanco, Merck Animal Health, Merial, Bayer Animal Health, Virbac, Ceva and Boehringer Ingelheim and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Virginiamycin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Virginiamycin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Virginiamycin Market Segment Percentages, by Type, 2021 (%)
- Poultry
- Aquaculture
- Others
Global Virginiamycin Market Segment Percentages, by Application, 2021 (%)
- Online Channels
- Supermarket/Hypermarket
- Specialty Store
- Others
Global Virginiamycin Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Virginiamycin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Virginiamycin revenues share in global market, 2021 (%)
Key companies Virginiamycin sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Virginiamycin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Phibro Animal Health Corporation
- Zoetis
- Elanco
- Merck Animal Health
- Merial
- Bayer Animal Health
- Virbac
- Ceva
- Boehringer Ingelheim
- Vetoquinol
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Virginiamycin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Virginiamycin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL VIRGINIAMYCIN OVERALL MARKET SIZE
2.1 Global Virginiamycin Market Size: 2021 VS 2028
2.2 Global Virginiamycin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Virginiamycin Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Virginiamycin Players in Global Market
3.2 Top Global Virginiamycin Companies Ranked by Revenue
3.3 Global Virginiamycin Revenue by Companies
3.4 Global Virginiamycin Sales by Companies
3.5 Global Virginiamycin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Virginiamycin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Virginiamycin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Virginiamycin Players in Global Market
3.8.1 List of Global Tier 1 Virginiamycin Companies
3.8.2 List of Global Tier 2 and Tier 3 Virginiamycin Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Virginiamycin Market Size Markets, 2021 & 2028
4.1.2 Poultry
4.1.3 Aquaculture
4.1.4 Others
4.2 By Type - Global Virginiamycin Revenue & Forecasts
4.2.1 By Type - Global Virginiamycin Revenue, 2017-2022
4.2.2 By Type - Global Virginiamycin Revenue, 2023-2028
4.2.3 By Type - Global Virginiamycin Revenue Market Share, 2017-2028
4.3 By Type - Global Virginiamycin Sales & Forecasts
4.3.1 By Type - Global Virginiamycin Sales, 2017-2022
4.3.2 By Type - Global Virginiamycin Sales, 2023-2028
4.3.3 By Type - Global Virginiamycin Sales Market Share, 2017-2028
4.4 By Type - Global Virginiamycin Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Virginiamycin Market Size, 2021 & 2028
5.1.2 Online Channels
5.1.3 Supermarket/Hypermarket
5.1.4 Specialty Store
5.1.5 Others
5.2 By Application - Global Virginiamycin Revenue & Forecasts
5.2.1 By Application - Global Virginiamycin Revenue, 2017-2022
5.2.2 By Application - Global Virginiamycin Revenue, 2023-2028
5.2.3 By Application - Global Virginiamycin Revenue Market Share, 2017-2028
5.3 By Application - Global Virginiamycin Sales & Forecasts
5.3.1 By Application - Global Virginiamycin Sales, 2017-2022
5.3.2 By Application - Global Virginiamycin Sales, 2023-2028
5.3.3 By Application - Global Virginiamycin Sales Market Share, 2017-2028
5.4 By Application - Global Virginiamycin Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Virginiamycin Market Size, 2021 & 2028
6.2 By Region - Global Virginiamycin Revenue & Forecasts
6.2.1 By Region - Global Virginiamycin Revenue, 2017-2022
6.2.2 By Region - Global Virginiamycin Revenue, 2023-2028
6.2.3 By Region - Global Virginiamycin Revenue Market Share, 2017-2028
6.3 By Region - Global Virginiamycin Sales & Forecasts
6.3.1 By Region - Global Virginiamycin Sales, 2017-2022
6.3.2 By Region - Global Virginiamycin Sales, 2023-2028
6.3.3 By Region - Global Virginiamycin Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Virginiamycin Revenue, 2017-2028
6.4.2 By Country - North America Virginiamycin Sales, 2017-2028
6.4.3 US Virginiamycin Market Size, 2017-2028
6.4.4 Canada Virginiamycin Market Size, 2017-2028
6.4.5 Mexico Virginiamycin Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Virginiamycin Revenue, 2017-2028
6.5.2 By Country - Europe Virginiamycin Sales, 2017-2028
6.5.3 Germany Virginiamycin Market Size, 2017-2028
6.5.4 France Virginiamycin Market Size, 2017-2028
6.5.5 U.K. Virginiamycin Market Size, 2017-2028
6.5.6 Italy Virginiamycin Market Size, 2017-2028
6.5.7 Russia Virginiamycin Market Size, 2017-2028
6.5.8 Nordic Countries Virginiamycin Market Size, 2017-2028
6.5.9 Benelux Virginiamycin Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Virginiamycin Revenue, 2017-2028
6.6.2 By Region - Asia Virginiamycin Sales, 2017-2028
6.6.3 China Virginiamycin Market Size, 2017-2028
6.6.4 Japan Virginiamycin Market Size, 2017-2028
6.6.5 South Korea Virginiamycin Market Size, 2017-2028
6.6.6 Southeast Asia Virginiamycin Market Size, 2017-2028
6.6.7 India Virginiamycin Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Virginiamycin Revenue, 2017-2028
6.7.2 By Country - South America Virginiamycin Sales, 2017-2028
6.7.3 Brazil Virginiamycin Market Size, 2017-2028
6.7.4 Argentina Virginiamycin Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Virginiamycin Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Virginiamycin Sales, 2017-2028
6.8.3 Turkey Virginiamycin Market Size, 2017-2028
6.8.4 Israel Virginiamycin Market Size, 2017-2028
6.8.5 Saudi Arabia Virginiamycin Market Size, 2017-2028
6.8.6 UAE Virginiamycin Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Phibro Animal Health Corporation
7.1.1 Phibro Animal Health Corporation Corporate Summary
7.1.2 Phibro Animal Health Corporation Business Overview
7.1.3 Phibro Animal Health Corporation Virginiamycin Major Product Offerings
7.1.4 Phibro Animal Health Corporation Virginiamycin Sales and Revenue in Global (2017-2022)
7.1.5 Phibro Animal Health Corporation Key News
7.2 Zoetis
7.2.1 Zoetis Corporate Summary
7.2.2 Zoetis Business Overview
7.2.3 Zoetis Virginiamycin Major Product Offerings
7.2.4 Zoetis Virginiamycin Sales and Revenue in Global (2017-2022)
7.2.5 Zoetis Key News
7.3 Elanco
7.3.1 Elanco Corporate Summary
7.3.2 Elanco Business Overview
7.3.3 Elanco Virginiamycin Major Product Offerings
7.3.4 Elanco Virginiamycin Sales and Revenue in Global (2017-2022)
7.3.5 Elanco Key News
7.4 Merck Animal Health
7.4.1 Merck Animal Health Corporate Summary
7.4.2 Merck Animal Health Business Overview
7.4.3 Merck Animal Health Virginiamycin Major Product Offerings
7.4.4 Merck Animal Health Virginiamycin Sales and Revenue in Global (2017-2022)
7.4.5 Merck Animal Health Key News
7.5 Merial
7.5.1 Merial Corporate Summary
7.5.2 Merial Business Overview
7.5.3 Merial Virginiamycin Major Product Offerings
7.5.4 Merial Virginiamycin Sales and Revenue in Global (2017-2022)
7.5.5 Merial Key News
7.6 Bayer Animal Health
7.6.1 Bayer Animal Health Corporate Summary
7.6.2 Bayer Animal Health Business Overview
7.6.3 Bayer Animal Health Virginiamycin Major Product Offerings
7.6.4 Bayer Animal Health Virginiamycin Sales and Revenue in Global (2017-2022)
7.6.5 Bayer Animal Health Key News
7.7 Virbac
7.7.1 Virbac Corporate Summary
7.7.2 Virbac Business Overview
7.7.3 Virbac Virginiamycin Major Product Offerings
7.7.4 Virbac Virginiamycin Sales and Revenue in Global (2017-2022)
7.7.5 Virbac Key News
7.8 Ceva
7.8.1 Ceva Corporate Summary
7.8.2 Ceva Business Overview
7.8.3 Ceva Virginiamycin Major Product Offerings
7.8.4 Ceva Virginiamycin Sales and Revenue in Global (2017-2022)
7.8.5 Ceva Key News
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Corporate Summary
7.9.2 Boehringer Ingelheim Business Overview
7.9.3 Boehringer Ingelheim Virginiamycin Major Product Offerings
7.9.4 Boehringer Ingelheim Virginiamycin Sales and Revenue in Global (2017-2022)
7.9.5 Boehringer Ingelheim Key News
7.10 Vetoquinol
7.10.1 Vetoquinol Corporate Summary
7.10.2 Vetoquinol Business Overview
7.10.3 Vetoquinol Virginiamycin Major Product Offerings
7.10.4 Vetoquinol Virginiamycin Sales and Revenue in Global (2017-2022)
7.10.5 Vetoquinol Key News
8 GLOBAL VIRGINIAMYCIN PRODUCTION CAPACITY, ANALYSIS
8.1 Global Virginiamycin Production Capacity, 2017-2028
8.2 Virginiamycin Production Capacity of Key Manufacturers in Global Market
8.3 Global Virginiamycin Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 VIRGINIAMYCIN SUPPLY CHAIN ANALYSIS
10.1 Virginiamycin Industry Value Chain
10.2 Virginiamycin Upstream Market
10.3 Virginiamycin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Virginiamycin Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Virginiamycin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Virginiamycin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL VIRGINIAMYCIN OVERALL MARKET SIZE
2.1 Global Virginiamycin Market Size: 2021 VS 2028
2.2 Global Virginiamycin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Virginiamycin Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Virginiamycin Players in Global Market
3.2 Top Global Virginiamycin Companies Ranked by Revenue
3.3 Global Virginiamycin Revenue by Companies
3.4 Global Virginiamycin Sales by Companies
3.5 Global Virginiamycin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Virginiamycin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Virginiamycin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Virginiamycin Players in Global Market
3.8.1 List of Global Tier 1 Virginiamycin Companies
3.8.2 List of Global Tier 2 and Tier 3 Virginiamycin Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Virginiamycin Market Size Markets, 2021 & 2028
4.1.2 Poultry
4.1.3 Aquaculture
4.1.4 Others
4.2 By Type - Global Virginiamycin Revenue & Forecasts
4.2.1 By Type - Global Virginiamycin Revenue, 2017-2022
4.2.2 By Type - Global Virginiamycin Revenue, 2023-2028
4.2.3 By Type - Global Virginiamycin Revenue Market Share, 2017-2028
4.3 By Type - Global Virginiamycin Sales & Forecasts
4.3.1 By Type - Global Virginiamycin Sales, 2017-2022
4.3.2 By Type - Global Virginiamycin Sales, 2023-2028
4.3.3 By Type - Global Virginiamycin Sales Market Share, 2017-2028
4.4 By Type - Global Virginiamycin Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Virginiamycin Market Size, 2021 & 2028
5.1.2 Online Channels
5.1.3 Supermarket/Hypermarket
5.1.4 Specialty Store
5.1.5 Others
5.2 By Application - Global Virginiamycin Revenue & Forecasts
5.2.1 By Application - Global Virginiamycin Revenue, 2017-2022
5.2.2 By Application - Global Virginiamycin Revenue, 2023-2028
5.2.3 By Application - Global Virginiamycin Revenue Market Share, 2017-2028
5.3 By Application - Global Virginiamycin Sales & Forecasts
5.3.1 By Application - Global Virginiamycin Sales, 2017-2022
5.3.2 By Application - Global Virginiamycin Sales, 2023-2028
5.3.3 By Application - Global Virginiamycin Sales Market Share, 2017-2028
5.4 By Application - Global Virginiamycin Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Virginiamycin Market Size, 2021 & 2028
6.2 By Region - Global Virginiamycin Revenue & Forecasts
6.2.1 By Region - Global Virginiamycin Revenue, 2017-2022
6.2.2 By Region - Global Virginiamycin Revenue, 2023-2028
6.2.3 By Region - Global Virginiamycin Revenue Market Share, 2017-2028
6.3 By Region - Global Virginiamycin Sales & Forecasts
6.3.1 By Region - Global Virginiamycin Sales, 2017-2022
6.3.2 By Region - Global Virginiamycin Sales, 2023-2028
6.3.3 By Region - Global Virginiamycin Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Virginiamycin Revenue, 2017-2028
6.4.2 By Country - North America Virginiamycin Sales, 2017-2028
6.4.3 US Virginiamycin Market Size, 2017-2028
6.4.4 Canada Virginiamycin Market Size, 2017-2028
6.4.5 Mexico Virginiamycin Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Virginiamycin Revenue, 2017-2028
6.5.2 By Country - Europe Virginiamycin Sales, 2017-2028
6.5.3 Germany Virginiamycin Market Size, 2017-2028
6.5.4 France Virginiamycin Market Size, 2017-2028
6.5.5 U.K. Virginiamycin Market Size, 2017-2028
6.5.6 Italy Virginiamycin Market Size, 2017-2028
6.5.7 Russia Virginiamycin Market Size, 2017-2028
6.5.8 Nordic Countries Virginiamycin Market Size, 2017-2028
6.5.9 Benelux Virginiamycin Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Virginiamycin Revenue, 2017-2028
6.6.2 By Region - Asia Virginiamycin Sales, 2017-2028
6.6.3 China Virginiamycin Market Size, 2017-2028
6.6.4 Japan Virginiamycin Market Size, 2017-2028
6.6.5 South Korea Virginiamycin Market Size, 2017-2028
6.6.6 Southeast Asia Virginiamycin Market Size, 2017-2028
6.6.7 India Virginiamycin Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Virginiamycin Revenue, 2017-2028
6.7.2 By Country - South America Virginiamycin Sales, 2017-2028
6.7.3 Brazil Virginiamycin Market Size, 2017-2028
6.7.4 Argentina Virginiamycin Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Virginiamycin Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Virginiamycin Sales, 2017-2028
6.8.3 Turkey Virginiamycin Market Size, 2017-2028
6.8.4 Israel Virginiamycin Market Size, 2017-2028
6.8.5 Saudi Arabia Virginiamycin Market Size, 2017-2028
6.8.6 UAE Virginiamycin Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Phibro Animal Health Corporation
7.1.1 Phibro Animal Health Corporation Corporate Summary
7.1.2 Phibro Animal Health Corporation Business Overview
7.1.3 Phibro Animal Health Corporation Virginiamycin Major Product Offerings
7.1.4 Phibro Animal Health Corporation Virginiamycin Sales and Revenue in Global (2017-2022)
7.1.5 Phibro Animal Health Corporation Key News
7.2 Zoetis
7.2.1 Zoetis Corporate Summary
7.2.2 Zoetis Business Overview
7.2.3 Zoetis Virginiamycin Major Product Offerings
7.2.4 Zoetis Virginiamycin Sales and Revenue in Global (2017-2022)
7.2.5 Zoetis Key News
7.3 Elanco
7.3.1 Elanco Corporate Summary
7.3.2 Elanco Business Overview
7.3.3 Elanco Virginiamycin Major Product Offerings
7.3.4 Elanco Virginiamycin Sales and Revenue in Global (2017-2022)
7.3.5 Elanco Key News
7.4 Merck Animal Health
7.4.1 Merck Animal Health Corporate Summary
7.4.2 Merck Animal Health Business Overview
7.4.3 Merck Animal Health Virginiamycin Major Product Offerings
7.4.4 Merck Animal Health Virginiamycin Sales and Revenue in Global (2017-2022)
7.4.5 Merck Animal Health Key News
7.5 Merial
7.5.1 Merial Corporate Summary
7.5.2 Merial Business Overview
7.5.3 Merial Virginiamycin Major Product Offerings
7.5.4 Merial Virginiamycin Sales and Revenue in Global (2017-2022)
7.5.5 Merial Key News
7.6 Bayer Animal Health
7.6.1 Bayer Animal Health Corporate Summary
7.6.2 Bayer Animal Health Business Overview
7.6.3 Bayer Animal Health Virginiamycin Major Product Offerings
7.6.4 Bayer Animal Health Virginiamycin Sales and Revenue in Global (2017-2022)
7.6.5 Bayer Animal Health Key News
7.7 Virbac
7.7.1 Virbac Corporate Summary
7.7.2 Virbac Business Overview
7.7.3 Virbac Virginiamycin Major Product Offerings
7.7.4 Virbac Virginiamycin Sales and Revenue in Global (2017-2022)
7.7.5 Virbac Key News
7.8 Ceva
7.8.1 Ceva Corporate Summary
7.8.2 Ceva Business Overview
7.8.3 Ceva Virginiamycin Major Product Offerings
7.8.4 Ceva Virginiamycin Sales and Revenue in Global (2017-2022)
7.8.5 Ceva Key News
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Corporate Summary
7.9.2 Boehringer Ingelheim Business Overview
7.9.3 Boehringer Ingelheim Virginiamycin Major Product Offerings
7.9.4 Boehringer Ingelheim Virginiamycin Sales and Revenue in Global (2017-2022)
7.9.5 Boehringer Ingelheim Key News
7.10 Vetoquinol
7.10.1 Vetoquinol Corporate Summary
7.10.2 Vetoquinol Business Overview
7.10.3 Vetoquinol Virginiamycin Major Product Offerings
7.10.4 Vetoquinol Virginiamycin Sales and Revenue in Global (2017-2022)
7.10.5 Vetoquinol Key News
8 GLOBAL VIRGINIAMYCIN PRODUCTION CAPACITY, ANALYSIS
8.1 Global Virginiamycin Production Capacity, 2017-2028
8.2 Virginiamycin Production Capacity of Key Manufacturers in Global Market
8.3 Global Virginiamycin Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 VIRGINIAMYCIN SUPPLY CHAIN ANALYSIS
10.1 Virginiamycin Industry Value Chain
10.2 Virginiamycin Upstream Market
10.3 Virginiamycin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Virginiamycin Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Virginiamycin in Global Market
Table 2. Top Virginiamycin Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Virginiamycin Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Virginiamycin Revenue Share by Companies, 2017-2022
Table 5. Global Virginiamycin Sales by Companies, (Kiloton), 2017-2022
Table 6. Global Virginiamycin Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Virginiamycin Price (2017-2022) & (US$/Ton)
Table 8. Global Manufacturers Virginiamycin Product Type
Table 9. List of Global Tier 1 Virginiamycin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Virginiamycin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Virginiamycin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Virginiamycin Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Virginiamycin Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Virginiamycin Sales (Kiloton), 2017-2022
Table 15. By Type - Global Virginiamycin Sales (Kiloton), 2023-2028
Table 16. By Application – Global Virginiamycin Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Virginiamycin Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Virginiamycin Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Virginiamycin Sales (Kiloton), 2017-2022
Table 20. By Application - Global Virginiamycin Sales (Kiloton), 2023-2028
Table 21. By Region – Global Virginiamycin Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Virginiamycin Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Virginiamycin Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Virginiamycin Sales (Kiloton), 2017-2022
Table 25. By Region - Global Virginiamycin Sales (Kiloton), 2023-2028
Table 26. By Country - North America Virginiamycin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Virginiamycin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Virginiamycin Sales, (Kiloton), 2017-2022
Table 29. By Country - North America Virginiamycin Sales, (Kiloton), 2023-2028
Table 30. By Country - Europe Virginiamycin Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Virginiamycin Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Virginiamycin Sales, (Kiloton), 2017-2022
Table 33. By Country - Europe Virginiamycin Sales, (Kiloton), 2023-2028
Table 34. By Region - Asia Virginiamycin Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Virginiamycin Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Virginiamycin Sales, (Kiloton), 2017-2022
Table 37. By Region - Asia Virginiamycin Sales, (Kiloton), 2023-2028
Table 38. By Country - South America Virginiamycin Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Virginiamycin Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Virginiamycin Sales, (Kiloton), 2017-2022
Table 41. By Country - South America Virginiamycin Sales, (Kiloton), 2023-2028
Table 42. By Country - Middle East & Africa Virginiamycin Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Virginiamycin Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Virginiamycin Sales, (Kiloton), 2017-2022
Table 45. By Country - Middle East & Africa Virginiamycin Sales, (Kiloton), 2023-2028
Table 46. Phibro Animal Health Corporation Corporate Summary
Table 47. Phibro Animal Health Corporation Virginiamycin Product Offerings
Table 48. Phibro Animal Health Corporation Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 49. Zoetis Corporate Summary
Table 50. Zoetis Virginiamycin Product Offerings
Table 51. Zoetis Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 52. Elanco Corporate Summary
Table 53. Elanco Virginiamycin Product Offerings
Table 54. Elanco Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 55. Merck Animal Health Corporate Summary
Table 56. Merck Animal Health Virginiamycin Product Offerings
Table 57. Merck Animal Health Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 58. Merial Corporate Summary
Table 59. Merial Virginiamycin Product Offerings
Table 60. Merial Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 61. Bayer Animal Health Corporate Summary
Table 62. Bayer Animal Health Virginiamycin Product Offerings
Table 63. Bayer Animal Health Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 64. Virbac Corporate Summary
Table 65. Virbac Virginiamycin Product Offerings
Table 66. Virbac Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 67. Ceva Corporate Summary
Table 68. Ceva Virginiamycin Product Offerings
Table 69. Ceva Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 70. Boehringer Ingelheim Corporate Summary
Table 71. Boehringer Ingelheim Virginiamycin Product Offerings
Table 72. Boehringer Ingelheim Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 73. Vetoquinol Corporate Summary
Table 74. Vetoquinol Virginiamycin Product Offerings
Table 75. Vetoquinol Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 76. Virginiamycin Production Capacity (Kiloton) of Key Manufacturers in Global Market, 2020-2022 (Kiloton)
Table 77. Global Virginiamycin Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Virginiamycin Production by Region, 2017-2022 (Kiloton)
Table 79. Global Virginiamycin Production by Region, 2023-2028 (Kiloton)
Table 80. Virginiamycin Market Opportunities & Trends in Global Market
Table 81. Virginiamycin Market Drivers in Global Market
Table 82. Virginiamycin Market Restraints in Global Market
Table 83. Virginiamycin Raw Materials
Table 84. Virginiamycin Raw Materials Suppliers in Global Market
Table 85. Typical Virginiamycin Downstream
Table 86. Virginiamycin Downstream Clients in Global Market
Table 87. Virginiamycin Distributors and Sales Agents in Global Market
Table 1. Key Players of Virginiamycin in Global Market
Table 2. Top Virginiamycin Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Virginiamycin Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Virginiamycin Revenue Share by Companies, 2017-2022
Table 5. Global Virginiamycin Sales by Companies, (Kiloton), 2017-2022
Table 6. Global Virginiamycin Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Virginiamycin Price (2017-2022) & (US$/Ton)
Table 8. Global Manufacturers Virginiamycin Product Type
Table 9. List of Global Tier 1 Virginiamycin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Virginiamycin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Virginiamycin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Virginiamycin Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Virginiamycin Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Virginiamycin Sales (Kiloton), 2017-2022
Table 15. By Type - Global Virginiamycin Sales (Kiloton), 2023-2028
Table 16. By Application – Global Virginiamycin Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Virginiamycin Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Virginiamycin Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Virginiamycin Sales (Kiloton), 2017-2022
Table 20. By Application - Global Virginiamycin Sales (Kiloton), 2023-2028
Table 21. By Region – Global Virginiamycin Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Virginiamycin Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Virginiamycin Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Virginiamycin Sales (Kiloton), 2017-2022
Table 25. By Region - Global Virginiamycin Sales (Kiloton), 2023-2028
Table 26. By Country - North America Virginiamycin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Virginiamycin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Virginiamycin Sales, (Kiloton), 2017-2022
Table 29. By Country - North America Virginiamycin Sales, (Kiloton), 2023-2028
Table 30. By Country - Europe Virginiamycin Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Virginiamycin Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Virginiamycin Sales, (Kiloton), 2017-2022
Table 33. By Country - Europe Virginiamycin Sales, (Kiloton), 2023-2028
Table 34. By Region - Asia Virginiamycin Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Virginiamycin Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Virginiamycin Sales, (Kiloton), 2017-2022
Table 37. By Region - Asia Virginiamycin Sales, (Kiloton), 2023-2028
Table 38. By Country - South America Virginiamycin Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Virginiamycin Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Virginiamycin Sales, (Kiloton), 2017-2022
Table 41. By Country - South America Virginiamycin Sales, (Kiloton), 2023-2028
Table 42. By Country - Middle East & Africa Virginiamycin Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Virginiamycin Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Virginiamycin Sales, (Kiloton), 2017-2022
Table 45. By Country - Middle East & Africa Virginiamycin Sales, (Kiloton), 2023-2028
Table 46. Phibro Animal Health Corporation Corporate Summary
Table 47. Phibro Animal Health Corporation Virginiamycin Product Offerings
Table 48. Phibro Animal Health Corporation Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 49. Zoetis Corporate Summary
Table 50. Zoetis Virginiamycin Product Offerings
Table 51. Zoetis Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 52. Elanco Corporate Summary
Table 53. Elanco Virginiamycin Product Offerings
Table 54. Elanco Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 55. Merck Animal Health Corporate Summary
Table 56. Merck Animal Health Virginiamycin Product Offerings
Table 57. Merck Animal Health Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 58. Merial Corporate Summary
Table 59. Merial Virginiamycin Product Offerings
Table 60. Merial Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 61. Bayer Animal Health Corporate Summary
Table 62. Bayer Animal Health Virginiamycin Product Offerings
Table 63. Bayer Animal Health Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 64. Virbac Corporate Summary
Table 65. Virbac Virginiamycin Product Offerings
Table 66. Virbac Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 67. Ceva Corporate Summary
Table 68. Ceva Virginiamycin Product Offerings
Table 69. Ceva Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 70. Boehringer Ingelheim Corporate Summary
Table 71. Boehringer Ingelheim Virginiamycin Product Offerings
Table 72. Boehringer Ingelheim Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 73. Vetoquinol Corporate Summary
Table 74. Vetoquinol Virginiamycin Product Offerings
Table 75. Vetoquinol Virginiamycin Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 76. Virginiamycin Production Capacity (Kiloton) of Key Manufacturers in Global Market, 2020-2022 (Kiloton)
Table 77. Global Virginiamycin Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Virginiamycin Production by Region, 2017-2022 (Kiloton)
Table 79. Global Virginiamycin Production by Region, 2023-2028 (Kiloton)
Table 80. Virginiamycin Market Opportunities & Trends in Global Market
Table 81. Virginiamycin Market Drivers in Global Market
Table 82. Virginiamycin Market Restraints in Global Market
Table 83. Virginiamycin Raw Materials
Table 84. Virginiamycin Raw Materials Suppliers in Global Market
Table 85. Typical Virginiamycin Downstream
Table 86. Virginiamycin Downstream Clients in Global Market
Table 87. Virginiamycin Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Virginiamycin Segment by Type
Figure 2. Virginiamycin Segment by Application
Figure 3. Global Virginiamycin Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Virginiamycin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Virginiamycin Revenue, 2017-2028 (US$, Mn)
Figure 7. Virginiamycin Sales in Global Market: 2017-2028 (Kiloton)
Figure 8. The Top 3 and 5 Players Market Share by Virginiamycin Revenue in 2021
Figure 9. By Type - Global Virginiamycin Sales Market Share, 2017-2028
Figure 10. By Type - Global Virginiamycin Revenue Market Share, 2017-2028
Figure 11. By Type - Global Virginiamycin Price (US$/Ton), 2017-2028
Figure 12. By Application - Global Virginiamycin Sales Market Share, 2017-2028
Figure 13. By Application - Global Virginiamycin Revenue Market Share, 2017-2028
Figure 14. By Application - Global Virginiamycin Price (US$/Ton), 2017-2028
Figure 15. By Region - Global Virginiamycin Sales Market Share, 2017-2028
Figure 16. By Region - Global Virginiamycin Revenue Market Share, 2017-2028
Figure 17. By Country - North America Virginiamycin Revenue Market Share, 2017-2028
Figure 18. By Country - North America Virginiamycin Sales Market Share, 2017-2028
Figure 19. US Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Virginiamycin Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Virginiamycin Sales Market Share, 2017-2028
Figure 24. Germany Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 25. France Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Virginiamycin Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Virginiamycin Sales Market Share, 2017-2028
Figure 33. China Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 37. India Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Virginiamycin Revenue Market Share, 2017-2028
Figure 39. By Country - South America Virginiamycin Sales Market Share, 2017-2028
Figure 40. Brazil Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Virginiamycin Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Virginiamycin Sales Market Share, 2017-2028
Figure 44. Turkey Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 48. Global Virginiamycin Production Capacity (Kiloton), 2017-2028
Figure 49. The Percentage of Production Virginiamycin by Region, 2021 VS 2028
Figure 50. Virginiamycin Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Virginiamycin Segment by Type
Figure 2. Virginiamycin Segment by Application
Figure 3. Global Virginiamycin Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Virginiamycin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Virginiamycin Revenue, 2017-2028 (US$, Mn)
Figure 7. Virginiamycin Sales in Global Market: 2017-2028 (Kiloton)
Figure 8. The Top 3 and 5 Players Market Share by Virginiamycin Revenue in 2021
Figure 9. By Type - Global Virginiamycin Sales Market Share, 2017-2028
Figure 10. By Type - Global Virginiamycin Revenue Market Share, 2017-2028
Figure 11. By Type - Global Virginiamycin Price (US$/Ton), 2017-2028
Figure 12. By Application - Global Virginiamycin Sales Market Share, 2017-2028
Figure 13. By Application - Global Virginiamycin Revenue Market Share, 2017-2028
Figure 14. By Application - Global Virginiamycin Price (US$/Ton), 2017-2028
Figure 15. By Region - Global Virginiamycin Sales Market Share, 2017-2028
Figure 16. By Region - Global Virginiamycin Revenue Market Share, 2017-2028
Figure 17. By Country - North America Virginiamycin Revenue Market Share, 2017-2028
Figure 18. By Country - North America Virginiamycin Sales Market Share, 2017-2028
Figure 19. US Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Virginiamycin Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Virginiamycin Sales Market Share, 2017-2028
Figure 24. Germany Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 25. France Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Virginiamycin Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Virginiamycin Sales Market Share, 2017-2028
Figure 33. China Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 37. India Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Virginiamycin Revenue Market Share, 2017-2028
Figure 39. By Country - South America Virginiamycin Sales Market Share, 2017-2028
Figure 40. Brazil Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Virginiamycin Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Virginiamycin Sales Market Share, 2017-2028
Figure 44. Turkey Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Virginiamycin Revenue, (US$, Mn), 2017-2028
Figure 48. Global Virginiamycin Production Capacity (Kiloton), 2017-2028
Figure 49. The Percentage of Production Virginiamycin by Region, 2021 VS 2028
Figure 50. Virginiamycin Industry Value Chain
Figure 51. Marketing Channels
